Human IgG Isotype Control

Supplier: MP Biomedicals
0855908
ICNA0855908EA 479 SGD
ICNA0855908
Human IgG Isotype Control
Antibodies
Product is the lyophilized powder of human IgG and buffer salts. All blood products should be treated as potentially infectious. Source material from which this product was derived was found negative when tested in accordance with current FDA required tests. No known test methods can offer assurance that products derived from human blood will not transmit infectious agents. The total protein is determined using the Biuret procedure, with bovine albumin as the standard. Each vial is overfilled by approximately 5 percent so that a minimum of 500 mg of human IgG is obtained upon reconstitution.
Order Now

SPECIFICATIONS

Environmentally Preferable
Antibody type Control
Conjugation Unconjugated
Reactivity
Host Human
Isotype IgG
ELISA Yes
Form Lyophilized
Purification Human IgG is purified from pooled human serum using multi-step procedures which may include salt fractionation, gel filtration, ion-exchange chromatography and immunoabsorption. The product is dialyzed into 0.01M sodium phosphate, 0.07M sodium chloride, pH 7.3, filtered through a 0.22 μm filter, vialed and lyophilized from a 30 ml solution. No preservative has been added.
Concentration Total Protein: 17.0 mg/mL, Volume: 30 mL
Shipping temperature RT

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR